scholarly journals Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial

2019 ◽  
Vol 176 (9) ◽  
pp. 1251-1267 ◽  
Author(s):  
Adrian J. Hobbs ◽  
Amie J. Moyes ◽  
Reshma S. Baliga ◽  
Dipa Ghedia ◽  
Rachel Ochiel ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Proof Of Concept ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Pulmonary Arterial ◽  
Neprilysin Inhibition

scholarly journals Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension

2013 ◽  
Vol 77 (10) ◽  
pp. 2619-2625 ◽  
Author(s):  
Yoshihiro Fukumoto ◽  
Norikazu Yamada ◽  
Hiromi Matsubara ◽  
Minori Mizoguchi ◽  
Kazuaki Uchino ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Kinase Inhibitor ◽  
Rho Kinase ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Rho Kinase Inhibitor ◽  
Pulmonary Arterial

Riociguat for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study (PATENT-1)

CHEST Journal ◽  
2012 ◽  
Vol 142 (4) ◽  
pp. 1027A ◽  
Author(s):  
Hossein Ghofrani ◽  
Nazzareno Galie ◽  
Friedrich Grimminger ◽  
Marc Humbert ◽  
Anne Keogh ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Pulmonary Arterial
Sign in / Sign up

Export Citation Format

Share Document